Comparative efficacy of certoparin, enoxaparin, and combined thromboprophylaxis on thromboembolic events after glioblastoma resection: a prospective observational study
Abstract Thromboembolic events (TE) are serious complications following glioblastoma (GBM) resection. This retrospective study analyzed 695 GBM patients (2017–2022, University Hospital Dresden) to assess the impact of different anticoagulant regimens—certoparin, enoxaparin, and enoxaparin with inter...
Saved in:
| Main Authors: | Eva Wardenbach, Dino Podlesek, Boshr Alhasan, Ahmed Abouelhamd, Ilker Y. Eyüpoglu, Tareq A. Juratli, Witold H. Polanski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-07899-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study
by: Xiaofeng Zheng, et al.
Published: (2025-05-01) -
Temporal Muscle Thickness as a Prognostic Marker in a Real‐Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis
by: Lazaros Lazaridis, et al.
Published: (2025-04-01) -
Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study
by: Salam Ibrahim Abou Safrah, et al.
Published: (2025-05-01) -
The incidence of venous thromboembolism is low when risk stratification-based thromboprophylaxis is used after fast-track hip and knee arthroplasty
by: Annette M Moisander, et al.
Published: (2024-12-01) -
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?
by: I. S. Yavelov
Published: (2011-12-01)